Cargando…

Clinical Characteristics and Outcomes in Patients Undergoing Primary or Secondary Enucleation or Evisceration After Ocular Trauma

PURPOSE: To investigate the frequency of primary versus secondary eye removal, frequency of enucleation versus evisceration, and characteristics and outcomes of patients undergoing these procedures after presenting with severe ocular trauma. PATIENTS AND METHODS: Retrospective chart review of patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Gauthier, Angela C, Oduyale, Oluseye K, Fliotsos, Michael J, Zafar, Sidra, Mahoney, Nicholas R, Srikumaran, Divya, Woreta, Fasika A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7602916/
https://www.ncbi.nlm.nih.gov/pubmed/33149543
http://dx.doi.org/10.2147/OPTH.S273760
_version_ 1783603797177663488
author Gauthier, Angela C
Oduyale, Oluseye K
Fliotsos, Michael J
Zafar, Sidra
Mahoney, Nicholas R
Srikumaran, Divya
Woreta, Fasika A
author_facet Gauthier, Angela C
Oduyale, Oluseye K
Fliotsos, Michael J
Zafar, Sidra
Mahoney, Nicholas R
Srikumaran, Divya
Woreta, Fasika A
author_sort Gauthier, Angela C
collection PubMed
description PURPOSE: To investigate the frequency of primary versus secondary eye removal, frequency of enucleation versus evisceration, and characteristics and outcomes of patients undergoing these procedures after presenting with severe ocular trauma. PATIENTS AND METHODS: Retrospective chart review of patients presenting to the emergency department (ED) with severe eye trauma necessitating enucleation or evisceration between 2010 and 2018. RESULTS: There were 92 eyes from 90 patients included in our study. Twenty-seven percent of eyes underwent primary removal (n=25, 14 enucleation, 11 evisceration), while 73% of eyes underwent secondary removal (n=67, 50 enucleation, 17 evisceration). The mean patient age was 45.2 years (range 4.2–92.6); primary enucleation/evisceration patients were older on average than secondary eye removal patients [53.8 years (range 15.9–91.2) versus 42.2 years (range 4.2–91.6 years), p=0.04]. A median of 34 days passed between ED presentation and secondary enucleation/evisceration. Before undergoing secondary enucleation/evisceration, patients underwent a median of one ocular procedure (range 0–14) for various complications of trauma including orbital infection, choroidal or retinal tear or detachment, and wound dehiscence. Open globe injury repairs comprised 43 of the 92 total procedures (47%) performed prior to secondary enucleation/evisceration. Secondary enucleations/eviscerations required a median of seven clinic visits compared to two clinic visits required after primary surgeries (p<0.01). 10.7% of all patients (n=10) had at least one implant-related complication following enucleation/evisceration, with all but one of these patients being in the secondary enucleation/evisceration group. CONCLUSION: Primary enucleation or evisceration was performed in 27% of all eye removals, and enucleation was performed in 69.6% of all eye removals. Future research is warranted to determine if primary eye removal may be appropriate and when to consider enucleation versus evisceration.
format Online
Article
Text
id pubmed-7602916
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-76029162020-11-03 Clinical Characteristics and Outcomes in Patients Undergoing Primary or Secondary Enucleation or Evisceration After Ocular Trauma Gauthier, Angela C Oduyale, Oluseye K Fliotsos, Michael J Zafar, Sidra Mahoney, Nicholas R Srikumaran, Divya Woreta, Fasika A Clin Ophthalmol Original Research PURPOSE: To investigate the frequency of primary versus secondary eye removal, frequency of enucleation versus evisceration, and characteristics and outcomes of patients undergoing these procedures after presenting with severe ocular trauma. PATIENTS AND METHODS: Retrospective chart review of patients presenting to the emergency department (ED) with severe eye trauma necessitating enucleation or evisceration between 2010 and 2018. RESULTS: There were 92 eyes from 90 patients included in our study. Twenty-seven percent of eyes underwent primary removal (n=25, 14 enucleation, 11 evisceration), while 73% of eyes underwent secondary removal (n=67, 50 enucleation, 17 evisceration). The mean patient age was 45.2 years (range 4.2–92.6); primary enucleation/evisceration patients were older on average than secondary eye removal patients [53.8 years (range 15.9–91.2) versus 42.2 years (range 4.2–91.6 years), p=0.04]. A median of 34 days passed between ED presentation and secondary enucleation/evisceration. Before undergoing secondary enucleation/evisceration, patients underwent a median of one ocular procedure (range 0–14) for various complications of trauma including orbital infection, choroidal or retinal tear or detachment, and wound dehiscence. Open globe injury repairs comprised 43 of the 92 total procedures (47%) performed prior to secondary enucleation/evisceration. Secondary enucleations/eviscerations required a median of seven clinic visits compared to two clinic visits required after primary surgeries (p<0.01). 10.7% of all patients (n=10) had at least one implant-related complication following enucleation/evisceration, with all but one of these patients being in the secondary enucleation/evisceration group. CONCLUSION: Primary enucleation or evisceration was performed in 27% of all eye removals, and enucleation was performed in 69.6% of all eye removals. Future research is warranted to determine if primary eye removal may be appropriate and when to consider enucleation versus evisceration. Dove 2020-10-27 /pmc/articles/PMC7602916/ /pubmed/33149543 http://dx.doi.org/10.2147/OPTH.S273760 Text en © 2020 Gauthier et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Gauthier, Angela C
Oduyale, Oluseye K
Fliotsos, Michael J
Zafar, Sidra
Mahoney, Nicholas R
Srikumaran, Divya
Woreta, Fasika A
Clinical Characteristics and Outcomes in Patients Undergoing Primary or Secondary Enucleation or Evisceration After Ocular Trauma
title Clinical Characteristics and Outcomes in Patients Undergoing Primary or Secondary Enucleation or Evisceration After Ocular Trauma
title_full Clinical Characteristics and Outcomes in Patients Undergoing Primary or Secondary Enucleation or Evisceration After Ocular Trauma
title_fullStr Clinical Characteristics and Outcomes in Patients Undergoing Primary or Secondary Enucleation or Evisceration After Ocular Trauma
title_full_unstemmed Clinical Characteristics and Outcomes in Patients Undergoing Primary or Secondary Enucleation or Evisceration After Ocular Trauma
title_short Clinical Characteristics and Outcomes in Patients Undergoing Primary or Secondary Enucleation or Evisceration After Ocular Trauma
title_sort clinical characteristics and outcomes in patients undergoing primary or secondary enucleation or evisceration after ocular trauma
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7602916/
https://www.ncbi.nlm.nih.gov/pubmed/33149543
http://dx.doi.org/10.2147/OPTH.S273760
work_keys_str_mv AT gauthierangelac clinicalcharacteristicsandoutcomesinpatientsundergoingprimaryorsecondaryenucleationoreviscerationafteroculartrauma
AT oduyaleoluseyek clinicalcharacteristicsandoutcomesinpatientsundergoingprimaryorsecondaryenucleationoreviscerationafteroculartrauma
AT fliotsosmichaelj clinicalcharacteristicsandoutcomesinpatientsundergoingprimaryorsecondaryenucleationoreviscerationafteroculartrauma
AT zafarsidra clinicalcharacteristicsandoutcomesinpatientsundergoingprimaryorsecondaryenucleationoreviscerationafteroculartrauma
AT mahoneynicholasr clinicalcharacteristicsandoutcomesinpatientsundergoingprimaryorsecondaryenucleationoreviscerationafteroculartrauma
AT srikumarandivya clinicalcharacteristicsandoutcomesinpatientsundergoingprimaryorsecondaryenucleationoreviscerationafteroculartrauma
AT woretafasikaa clinicalcharacteristicsandoutcomesinpatientsundergoingprimaryorsecondaryenucleationoreviscerationafteroculartrauma